If it hits that target, Volcano’s full-year sales will amount to nearly $392 million, a jump of about 10% over 2011.
There’s been too much turnover in the corner office at Boston Scientific (NYSE:BSX), and Michael Mahoney aims to change that, he told an audience at the J.P. Morgan Healthcare Conference in San Francisco today.
"I’m really making a long-term commitment to the company," Mahoney said today. "I absolutely love it, I’m enjoying what I’m doing."
Medical device company Zimmer Holdings (NYSE:ZMH) is well-prepared to weather the burden of the new medical device tax, chairman & CEO David Dvorak told an audience at the J.P. Morgan healthcare conference in San Francisco today.
The company has spent many years streamlining its operations and looking for ways to cut costs in order to prepare for the tax, which took effect Jan. 1.
The Minnesota device maker now expects earnings-per-share in the range of $3.66-$3.70 for fiscal year 2013, from previous guidance in the range of $3.62-$3.70, CEO Omar Ishrak told an audience at the J.P. Morgan Healthcare conference in San Francisco today.
Just a few days into his tenure as CEO of Medtronic (NYSE:MDT), Omar Ishrak was confronted with a major crisis: The Spine Journal devoted its entire June issue to to exposing problems with growth proteins, including a repudiation of some of the research surrounding Infuse.
Medical devices will contribute about 27% of Abbott’s (NYSE:ABT) sales after it spins out its research pharmaceuticals unit later this year, CFO Thomas Freyman said today at the J.P. Morgan health care conference in San Francisco.
Abbott announced its plan to split into two publicly traded companies late last year, creating a new entity for the research pharma unit and keeping the Abbott name for the remaining medical products businesses.
Say hello to a special edition of MassDevice +3, a bite-sized view of the top three med-tech stories coming out of the JP Morgan health care conference in San Francisco. Stay tuned the rest of this week for more breaking medical device news!
If you read nothing else today, make sure you’re still in the know with MassDevice +3.